These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 24565005)

  • 1. Clinical pharmacology in the development of new antidepressants: the challenges.
    Alexander RC; Preskorn S
    Curr Opin Pharmacol; 2014 Feb; 14():6-10. PubMed ID: 24565005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New trends in the neurobiology and pharmacology of affective disorders.
    LasoĊ„ W; Budziszewska B; Basta-Kaim A; Kubera M; Maes M
    Pharmacol Rep; 2013; 65(6):1441-50. PubMed ID: 24552991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants.
    Alhaj H; Wisniewski G; McAllister-Williams RH
    J Psychopharmacol; 2011 Sep; 25(9):1175-91. PubMed ID: 21106608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development.
    Katz MM; Bowden CL; Berman N; Frazer A
    J Clin Psychopharmacol; 2006 Dec; 26(6):549-53. PubMed ID: 17110809
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal models of depression: challenges from a drug development perspective.
    Rupniak NM
    Behav Pharmacol; 2003 Sep; 14(5-6):385-90. PubMed ID: 14501252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The keys to improving depression outcomes.
    Rizvi SJ; Kennedy SH
    Eur Neuropsychopharmacol; 2011 Sep; 21 Suppl 4():S694-702. PubMed ID: 21924209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression, antidepressants, and peripheral blood components.
    Fisar Z; Raboch J
    Neuro Endocrinol Lett; 2008 Feb; 29(1):17-28. PubMed ID: 18283265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants.
    Hill MN; Hillard CJ; Bambico FR; Patel S; Gorzalka BB; Gobbi G
    Trends Pharmacol Sci; 2009 Sep; 30(9):484-93. PubMed ID: 19732971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal temporal difference reward-learning signals in major depression.
    Kumar P; Waiter G; Ahearn T; Milders M; Reid I; Steele JD
    Brain; 2008 Aug; 131(Pt 8):2084-93. PubMed ID: 18579575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy for geriatric depression.
    Bressler R; Katz MD
    Drugs Aging; 1993; 3(3):195-219. PubMed ID: 8324296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment of unipolar depression.
    Anderson IM
    Curr Top Behav Neurosci; 2013; 14():263-89. PubMed ID: 22544348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Depression and neuroplasticity].
    Pitchot W; Polis M; Belachew S; Ansseau M
    Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression.
    Saletu B; Anderer P; Saletu-Zyhlarz GM
    Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.
    Hafizi S; Chandra P; Cowen J
    Br J Psychiatry; 2007 Oct; 191():282-4. PubMed ID: 17906236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and EEG effects of GB-94, a "tetracyclic" antidepressant (EEG model in discovery of a new psychotropic drug).
    Itil TM; Polvan N; Hsu W
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):395-413. PubMed ID: 4625520
    [No Abstract]   [Full Text] [Related]  

  • 17. Research and treatment approaches to depression.
    Wong ML; Licinio J
    Nat Rev Neurosci; 2001 May; 2(5):343-51. PubMed ID: 11331918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.
    Leuchter A; Cook IA; Hunter AM
    J Psychopharmacol; 2012 Aug; 26(8):1162-3; author reply 1164. PubMed ID: 22807041
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of antidepressants.
    Richelson E
    Mayo Clin Proc; 2001 May; 76(5):511-27. PubMed ID: 11357798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.